Compare McKesson Corporation (MCK) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs TeraWulf Inc — how do they compare? McKesson Corporation trades at $832.45 (market cap $97.35B), while TeraWulf Inc trades at $19.94 (market cap $9.35B). The key difference: McKesson Corporation is far larger — about 10.4× TeraWulf Inc's market cap, and McKesson Corporation pays a 0.39% dividend while TeraWulf Inc pays none. Which is the better fit depends on your goals.
| MCK | WULF | |
|---|---|---|
Market Cap | $97.35B | $9.35B |
Sector | Health | Technology |
52-Week High | $995.69 | $28.98 |
52-Week Low | $659.01 | $4.76 |
Enterprise Value | $101.98B | $12.03B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WULF trades at $18.86, up 3.85% today, but remains in a bearish technical trend. The company reported a net loss of -$661.42M in 2025 with a -611.46% net margin, though it secured a significant 20-year, $19B AI infrastructure deal with Anthropic. Analyst consensus is unanimously bullish with a $37.22 price target, citing long-term AI data center growth potential despite near-term profitability challenges.
The outlook hinges on successful execution of the Anthropic partnership to drive future revenue, but high valuation multiples and persistent losses pose substantial risks. Investors face volatility from operational cash burn and sector sentiment swings, requiring careful risk assessment against transformative AI infrastructure opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
